-
Amgen Inc. v. Amneal Pharmaceuticals LLC et al DC CAFC
- 1:16-cv-00925
- D. Del.
- Judge: Mitchell S. Goldberg
- Filed: 10/11/2016
- Closed: 09/08/2020
- Latest Docket Entry: 09/08/2020
- PACER
1
Plaintiff
3
Defendants
1
Accused
Product
1
Patent-in-Suit
1,429
Days in
Litigation
-
Amgen Inc. v. Amneal Pharmaceuticals LLC et al DC CAFC
- 1:16-cv-00925
- D. Del.
- Judge: Mitchell S. Goldberg
- Filed: 10/11/2016
- Closed: 09/08/2020
- Latest Docket Entry: 09/08/2020
- PACER
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim | Outcome |
|---|---|
| All challenged claims |
Enforceable and Valid
Entry 34 |
-
Infringement
Amneal Pharmaceuticals, LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic Version EQ 30 mg Cinacalcet Hydrochloride tabletsGeneric Version EQ 60 mg Cinacalcet Hydrochloride tabletsGeneric Version EQ 90 mg Cinacalcet Hydrochloride tablets | US 9,375,405 B2 | All Asserted Claims |
Infringement
Entry 34
|
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic Version EQ 30 mg Cinacalcet Hydrochloride tabletsGeneric Version EQ 60 mg Cinacalcet Hydrochloride tabletsGeneric Version EQ 90 mg Cinacalcet Hydrochloride tablets | US 9,375,405 B2 | All Asserted Claims |
Infringement
Entry 34
|
